Guidelines

Vapes and Snus: What the ESC Says About Cardiovascular Risk

The European Society of Cardiology has clarified its position on electronic cigarettes and snus, outlining distinct cardiovascular risks.

AF-CARE Pathway: New ESC Guidelines Streamline AFib Management

The 2024 ESC AFib Guidelines introduce the AF-CARE pathway, emphasizing early diagnosis, comprehensive risk factor management, and integrated care.

Universal Heart Failure Definition Issued by Global Societies

Four major cardiology societies released a universal definition of heart failure, aiming to standardise diagnosis and research across the globe.

PRISMA 2020: Updated Guideline for Systematic Reviews

The PRISMA 2020 statement provides an updated framework for reporting systematic reviews, enhancing transparency and completeness.

SPIRIT-ROUTINE Checklist Improves RCT Protocol Reporting for Routinely Collected Data

A new extension to the SPIRIT 2025 guideline, SPIRIT-ROUTINE, aims to enhance transparency and completeness in randomised controlled trial protocols using routinely collected data.

IPDAS 5.0 Updates: Enhanced Standards for Patient Decision Aids

The International Patient Decision Aid Standards (IPDAS) have been updated to version 5.0, incorporating new evidence and an expanded scope.

ACP Issues Guidance on Medications for Obesity, Overweight

The American College of Physicians (ACP) has released new guidance on pharmacologic treatments for obesity and overweight, focusing on efficacy and safety.

Psoriasis Workup Expands Beyond Skin: SDPA 2026 Highlights Systemic Risk

Psoriasis management is evolving, with new guidance emphasizing systemic comorbidities beyond dermatological manifestations.

Cardio-Oncology Guidelines: Standardizing CTRCD Management

A consensus statement provides practical guidance for hematology and oncology providers on managing cancer therapy-related cardiac dysfunction (CTRCD).